• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


H&T Presspart Low GWP Banner
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

Nycomed and Orion to co-market Easyhaler DPI products for asthma and COPD

Finnish pharmaceutical company Orion Corporation will co-market combination products delivered by its Easyhaler dry powder inhaler with Nycomed. The agreement covers major European countries, the Middle East, and North Africa. Orion will manufacture the products and will maintain exclusive rights in the UK, Eastern Europe, and the Nordic countries. Each company will market products under their own brands.

Orion has been developing several combination DPIs for the treatment of asthma and COPD, a budesonide/formoterol combination and a fluticasone/salmeterol combination. Four single therapy formulations in Easyhaler products are currently available in 25 countries: beclametasone, budesonide, formoterol, and salbutamol.

Dr. Liisa Hurme, Senior VP of Orion’s Proprietary Products division, commented: “I am excited about the collaboration agreement and look forward to having such a strong partner focusing on the treatment of asthma and chronic obstructive pulmonary disease. The collaboration creates a momentum for Easyhaler products in Europe and strengthens Orion’s strategic objective to become a stronger player in the field of respiratory medication.”

Nycomed Executive VP of Commercial Operations Guido Oelkers addes, “We are very pleased to have signed this collaboration agreement with Orion. We see great potential in these high quality Easyhaler products in major European countries and the MENA region. They will significantly enhance Nycomed’s fast-growing Respiratory portfolio.”

Read the Nycomed and Orion press release.

Share

published on August 4, 2011

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Bespak Leading the Green Transition banner
    © 2025 OINDPnews